A highly sensitive fluorimetric method for determination of lenalidomide in its bulk form and capsules via derivatization with fluorescamine

BACKGROUND: Lenalidomide (LND) is a potent novel thalidomide analog which demonstrated remarkable clinical activity in treatment of multiple myeloma disease via a multiple-pathways mechanism. The strong evidences-based clinical success of LND in patients has led to its recent approval by US-FDA unde...

Descripción completa

Detalles Bibliográficos
Autores principales: Darwish, Ibrahim A, Khalil, Nasr Y, Bakheit, Ahmed H, Alzoman, Nourh Z
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537752/
https://www.ncbi.nlm.nih.gov/pubmed/23068782
http://dx.doi.org/10.1186/1752-153X-6-118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3537752/
https://www.ncbi.nlm.nih.gov/pubmed/23068782
http://dx.doi.org/10.1186/1752-153X-6-118

Ejemplares similares